Table 2.

Experimental groups.

Group	Dose plan
Group 1	Normal control
Group 2	Normal + HBAO (60 mg/kg p.o.) continued for 45 days.
Group 3	Diabetic control (Infused with STZ 60 mg/kg i.p)
Group 4	Diabetic + HBAO (20 mg/kg p.o.) and continued for 45 days
Group 5	Diabetic + HBAO (40 mg/kg p.o.) and continued for 45 days.
Group 6	Diabetic + HBAO (60 mg/kg p.o.) and continued for 45 days
Group 7	Diabetic + Glibenclamide (10mg/kg p.o.) and continued for 45 days